303 related articles for article (PubMed ID: 32619305)
21. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A
Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720
[TBL] [Abstract][Full Text] [Related]
22. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.
Dias-Santagata D; Lam Q; Vernovsky K; Vena N; Lennerz JK; Borger DR; Batchelor TT; Ligon KL; Iafrate AJ; Ligon AH; Louis DN; Santagata S
PLoS One; 2011 Mar; 6(3):e17948. PubMed ID: 21479234
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
[TBL] [Abstract][Full Text] [Related]
24. BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review.
Kata K; Rodriguez-Quintero JC; Arevalo OD; Zhang JJ; Bhattacharjee MB; Ware C; Dono A; Riascos-Castaneda R; Tandon N; Blanco A; Esquenazi Y; Ballester LY; Amsbaugh M; Day AL; Zhu JJ
J Natl Compr Canc Netw; 2022 Nov; 20(11):1193-1202.e6. PubMed ID: 36351333
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma.
Nakamura T; Fukuoka K; Nakano Y; Yamasaki K; Matsushita Y; Yamashita S; Ikeda J; Udaka N; Tanoshima R; Shiba N; Tateishi K; Yamanaka S; Yamamoto T; Hirato J; Ichimura K
Cancer Sci; 2019 Feb; 110(2):828-832. PubMed ID: 30609203
[TBL] [Abstract][Full Text] [Related]
26. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases.
Vizcaino MA; Giannini C; Lalich D; Nael A; Jenkins RB; Tran Q; Orr BA; Abdullaev Z; Aldape K; Vaubel RA
J Neuropathol Exp Neurol; 2024 May; 83(6):416-424. PubMed ID: 38699943
[TBL] [Abstract][Full Text] [Related]
27. Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
Tang K; Kurland D; Vasudevaraja V; Serrano J; Delorenzo M; Radmanesh A; Thomas C; Spino M; Gardner S; Allen JC; Nicolaides T; Osorio DS; Finlay JL; Boué DR; Snuderl M
J Neuropathol Exp Neurol; 2020 Aug; 79(8):880-890. PubMed ID: 32594172
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.
Watanabe N; Ishikawa E; Kohzuki H; Sakamoto N; Zaboronok A; Matsuda M; Shibuya M; Matsumura A
BMC Neurol; 2020 Jan; 20(1):21. PubMed ID: 31941461
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion.
Damayanti NP; Saadatzadeh MR; Dobrota E; Ordaz JD; Bailey BJ; Pandya PH; Bijangi-Vishehsaraei K; Shannon HE; Alfonso A; Coy K; Trowbridge M; Sinn AL; Zhang ZY; Gallagher RI; Wulfkuhle J; Petricoin E; Richardson AM; Marshall MS; Lion A; Ferguson MJ; Balsara KE; Pollok KE
Sci Rep; 2023 Jun; 13(1):9163. PubMed ID: 37280243
[TBL] [Abstract][Full Text] [Related]
30. Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group.
Ono T; Sasajima T; Shimizu H; Natsumeda M; Kanamori M; Asano K; Beppu T; Matsuda K; Ichikawa M; Fujii Y; Ohkuma H; Ogasawara K; Sonoda Y; Saito K; Nobusawa S; Nakazato Y; Kitanaka C; Kayama T; Tominaga T;
Neurol Med Chir (Tokyo); 2020 Nov; 60(11):543-552. PubMed ID: 33071274
[TBL] [Abstract][Full Text] [Related]
31. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
Pratt D; Abdullaev Z; Papanicolau-Sengos A; Ketchum C; Panneer Selvam P; Chung HJ; Lee I; Raffeld M; Gilbert MR; Armstrong TS; Pytel P; Borys E; Klonoski JM; McCord M; Horbinski C; Brat D; Perry A; Solomon D; Eberhart C; Giannini C; Quezado M; Aldape K
Acta Neuropathol; 2022 Mar; 143(3):403-414. PubMed ID: 35103816
[TBL] [Abstract][Full Text] [Related]
32. BRAF Inhibition in
Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
[TBL] [Abstract][Full Text] [Related]
33. Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.
Wang Y; Wang L; Blümcke I; Zhang W; Fu Y; Shan Y; Piao Y; Zhao G
Brain Pathol; 2022 Jan; 32(1):e13011. PubMed ID: 34355449
[TBL] [Abstract][Full Text] [Related]
34. Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults.
Shi ZF; Li KK; Huang QJ; Wang WW; Kwan JS; Chen H; Liu XZ; Li WC; Chan DT; Zhang ZY; Mao Y; Ng HK
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12802. PubMed ID: 35191072
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
36. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
Perkins SM; Mitra N; Fei W; Shinohara ET
J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 expression in ganglioglioma, pleomorphic xanthoastrocytoma and pilocytic astrocytoma.
Forest F; Dal Col P; Laville D; Court A; Rillardon M; Ramirez C; Rivoirard R; Stephan JL; Vassal F; Péoc'h M
Exp Mol Pathol; 2021 Aug; 121():104652. PubMed ID: 34022185
[TBL] [Abstract][Full Text] [Related]
38. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
[TBL] [Abstract][Full Text] [Related]
39. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
40. Molecular genetic alterations in pleomorphic xanthoastrocytoma.
Paulus W; Lisle DK; Tonn JC; Wolf HK; Roggendorf W; Reeves SA; Louis DN
Acta Neuropathol; 1996; 91(3):293-7. PubMed ID: 8834542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
